MERILEE RAINES
CIK 1023869 · Executive VP & CFO · last filed 2026-08-04
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$34.49M
Companies
7
Total Filings
68
Lifetime Open-Market Net
-$38.68M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| WTS | Director | 21,670 | $377.12 | $8.17M | $0 | 17 | 2026-08-04 |
| OCUL | Director | 60,933 | $8.74 | $532.6K | $0 | 6 | 2026-06-12 |
| TMDX | Director | 6,981 | $80.21 | $559.9K | $0 | 7 | 2026-05-22 |
| BHE | Director | 24,489 | $82.37 | $2.02M | $0 | 3 | 2021-05-14 |
| ARATANA THERAPEUTICS, INC. (PETX) Delisted | Director | 0 | — | — | $0 | 7 | 2019-07-18 |
| AFFYMETRIX INC (AFFX) Delisted | Director | 0 | — | — | $0 | 3 | 2016-04-01 |
| IDXX | Executive VP & CFO | 39,332 | $590.00 | $23.21M | -$38.68M | 25 | 2013-02-27 |
Recent Filings · Page 6 of 7
68 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2012-08-10 | IDXX | Mixed | — | -$510.9K | EDGAR |
| 2012-08-06 | WTS | Grant (A) | +2,405 | $0 | EDGAR |
| 2012-05-08 | IDXX | Mixed | — | -$535.2K | EDGAR |
| 2012-02-16 | IDXX | Mixed | +1,357 | -$58.5K | EDGAR |
| 2011-08-16 | IDXX | Mixed | +11,800 | -$614.0K | EDGAR |
| 2011-08-09 | WTS | Grant (A) | +2,065 | $0 | EDGAR |
| 2011-03-02 | WTS | Grant (A) | +400 | $0 | EDGAR |
| 2011-02-16 | IDXX | Mixed | +1,313 | -$50.7K | EDGAR |
| 2010-08-11 | IDXX | Mixed | +24,500 | -$1.19M | EDGAR |
| 2010-02-17 | IDXX | Mixed | +979 | -$30.2K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.